News | March 12, 2015

Many People with Congenital Heart Disease Living Longer

Increasing diagnoses of CHD attributed to better early detection methods

Congenital heart disease in adults is becoming more common as childhood treatments become more effective, according to a study from Penn State Hershey.

Congenital heart disease in adults is becoming more common as childhood treatments become more effective, according to a study from Penn State Hershey.

March 12, 2015 — At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth Adams, M.D., of Penn State Hershey Children's Heart Group, can predict that a child born today has a 90 percent chance of living to adulthood, even with severe CHD.

"Most children with CHD are now living to adulthood and historically that has not been the case," she said.

The Adult Congenital Heart Association (ACHA) now reports that there are an estimated 2 million adults living with CHD in the United States, meaning that, for the first time ever, there are more adults than children with CHD.

Affecting about 1 percent of the population, CHD is a genetic condition and is present from birth.

"Most of what we're talking about are structural problems with the way the heart is formed – hearts that are missing chambers, hearts that have narrow or leaky valves, or structures that are not in the right place," Adams said.

CHD is usually detected prenatally via ultrasound during pregnancy followed by a cardiac ultrasound to confirm and identify a problem. Occasionally children are not diagnosed until after birth and most of those cases are identified within the first year of life. In some less serious cases, patients are not diagnosed until much later in life.

Early detection is possible today due to sophisticated ultrasound capabilities that are now commonly used and allow doctors to find the majority of the cases prenatally.

Less invasive procedures have also been developed that can spare patients open heart surgery.

"For example, if a baby is born today with a narrow pulmonary valve, that child will probably not need surgery," Adams said.

The child would undergo a cardiac catheter procedure where a balloon is inserted into the valve to open it without an operation. In some cases, adult valve replacement or repairing small holes can be done via catheter as well.

"Instead of a week in the hospital, it's one night plus a week of recovery time instead of a couple of months," Adams said.

The incidence of congenital heart disease is increasing slightly, probably related to better detection, and in some cases, genetic transmission of cases from parent to child.

Researchers are currently trying to understand the ways in which congenital heart defects are transmitted and why some are more likely to be passed on to offspring than others.

Watch the VIDEO "Addressing Adult Congenital Heart Referrals," a discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology, Massachusetts General Hospital, at the 2018 American College of Cardiology (ACC) meeting.

For more information: www.pennstatehershey.org

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
Videos | Cath Lab | September 14, 2018
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS.
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Overlay Init